Trials / Unknown
UnknownNCT00622882
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
Early Infectious Disease Consultation for Better Outcomes From Staphylococcus Aureus Bacteremia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- National University Hospital, Singapore · Academic / Other
- Sex
- All
- Age
- 1 Month
- Healthy volunteers
- Not accepted
Summary
The primary objective is to determine if early infectious disease (ID) consultation (defined as within 48 hours of a positive blood culture) will reduce mortality rates from Staphylococcus aureus bacteremia (SAB). This study will also determine if such consultations could reduce the duration of hospitalisation, recurrence and financial costs in patients with this infection.
Detailed description
Bacteremia is a serious manifestation of Staphylococcus aureus infection with an attributable mortality as high as 25% in MRSA bacteremia. More than a third of patients end up with complications such as endocarditis, osteomyelitis or pneumonia. Overall the outcome of patients with respect to mortality or recurrence is better in patients who have an eradicable focus and have received an appropriate antibiotic dose and duration. Also complicated bacteremia is more common in patients with * persistent bacteremia or fever * prosthetic device * new murmur * skin findings of a systemic infection Based on this evidence, an ID consultation could improve the outcomes of patients with SAB by * Advising adequate antibiotic dosage and duration * Sourcing out and counselling eradication of any focus of infection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | infectious disease specialist consultation | Randomised trial to determine the utility of an early Infectious disease Consultation in Staphylococcus aureus bacteremic patients ( in the first 48 hours of a positive blood culture) |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2008-02-25
- Last updated
- 2014-01-07
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT00622882. Inclusion in this directory is not an endorsement.